Topics

Frontline Immunotherapy Firmly Established for Select Patients With NSCLC

12:35 EST 11 Nov 2019 | OncLive

The use of immunotherapy, either as monotherapy or in combination with chemotherapy, continues to raise the bar with regard to overall survival benefit in patients with newly diagnosed, advanced nonsquamous non–small cell lung cancer.

Original Article: Frontline Immunotherapy Firmly Established for Select Patients With NSCLC

NEXT ARTICLE

More From BioPortfolio on "Frontline Immunotherapy Firmly Established for Select Patients With NSCLC"

Quick Search

Relevant Topics

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...

Lung Cancer
Lung cancer is the uncontrolled cell growth in tissues of the lung. Originating in the lungs, this growth may invade adjacent tissues and infiltrate beyond the lungs. Lung cancer, the most common cause of cancer-related death in men and women, is respons...